tbuckley/cabot-search huggingface dataset:
<i>Announcement:</i>National Kidney Month—March 2016
Journal: MMWR Morbidity and Mortality Weekly Report (2016)

March is designated National Kidney Month to raise awareness about the prevention and early detection of kidney disease. Approximately 10% (20 million) of U.S. adults aged ≥20 years have chronic kidney disease (CKD), and most of them are unaware of their condition. If left untreated, CKD can lead to kidney failure, requiring dialysis or transplantation for survival.
Anti-citrullinated protein antibodies have a low avidity compared to antibodies against recall-antigens
Authors: P Suwannalai, H U Scherer, D van der Woude, A Ioan-Facsinay, C M J.-v. der Zijde, M J van Tol, T W J Huizinga, R E M Toes, L A Trouw
Journal: Annals of the Rheumatic Diseases (2010)
Pacemaker Site: Its Choice May Influence Cardiac Function
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract P1-17-14: Physical activity platform to improve bone health in cancer survivors
Authors: Cathy Skinner
Journal: Cancer Research (2020)

Abstract Cancer treatment-induced bone loss and the subsequent risk of fractures in both men and women is a significant burden on national health care. The number of cancer survivors in the United States will reach 18 million by 2022 and by 2025, the projected burden of osteoporosis is $25.3 billion. Cancer patients treated with medications that lower hormone levels face an increased risk of fractures. Clinical studies report that moderate- intensity resistance exercises prevent a decline in bone health in female cancer survivors, and that strength training may reduce complications associated with cancer such as fatigue, muscle wasting, and bone loss. Unfortunately, only a small percentage of female cancer survivors engage in and adhere to a strength training exercise routine. Several factors account for this low level of engagement such as poor awareness of the benefits of exercise, lack of motivation, and the lack of affordable and easily accessible exercise programs designed for cancer survivors. Internet-based self-managed programs of exercises and guidance can potentially address these problems, and can be scaled for broader dissemination. The Thrivors™ internet-based platform seeks to shift the current paradigm of poor adherence to exercise by providing an affordable and accessible means of improving outcomes for cancer survivors. The product, Thrivors plus Bone Health (Thrivors+BH), will be a first-of-its-kind offering of clinically validated bone health exercises that can be customized to a cancer survivor's pain and energy levels, with several novel interactive feedback features. The product has supportive modules for connecting with a community of other users, mindfulness training, nutritional advice and a repository of educational information. The Thrivors™ platform is scalable, device-agnostic, and allows analysis of de-identified usage data. With commercialization potential for healthcare providers and health insurance payers, Thrivors™ provides a value-based care delivery model focused on outcomes. There are multiple important physiologic and psychosocial secondary conditions that could be positively impacted by the Thrivors™ platform. For this specific clinical trial, we focus on adherence to bone health exercises. Investigators: Cathy Skinner, MA - CEO and Founder, Thrivors (https://www.linkedin.com/in/cathyskinner/) Doug Yee, MD - Director of the Masonic Cancer Center, University of Minnesota (https://www.linkedin.com/in/douglas-yee-50402a14/) Kerri Winters-Stone, PhD - Professor, OHSU (https://www.linkedin.com/in/kerriwintersstone/) Kathryn Schmitz, PhD, MPH - Professor, Penn State - (https://www.linkedin.com/in/kathryn-schmitz-32a3891b/) Citation Format: Cathy Skinner. Physical activity platform to improve bone health in cancer survivors [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P1-17-14.
GLYCERINATED VERSUS DRIED VACCINE VIRUS.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma
Authors: K Takahashi
Journal: Hepatology (1993)

We investigated 24 hepatocellular carcinomas in Japan to find loss of heterozygosity with 15 polymorphic DNA markers that detect allelic losses at specific chromosome loci. Loss of heterozygosity on chromosomes 10q, 17p and 22q was detected in 3 of 12 (25%), 9 of 21 (43%) and 5 of 15 (33%) informative cases of hepatocellular carcinoma, respectively. This is the first report of loss of heterozygosity on chromosome 22q in hepatocellular carcinoma; the newly recognized common chromosome loss was considered to exist between D22S9 and D22S10 on 22q11. On the basis of this and other studies, we believe it is likely that such a chromosome loss in hepatocellular carcinoma is a signal for malignant transformation and that loss of unknown genes on chromosomes 10q, 17p and 22q may contribute to tumor progression in hepatocellular carcinoma. (HEPATOLOGY 1993;17:794–799.)
Treatment After Operation.
Journal: JAMA (1913)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Health Impacts of Climate Change and Ozone Depletion: An Ecoepidemiologic Modeling Approach
Authors: W. J. M. Martens
Journal: Environmental Health Perspectives (1998)

Anthropogenic climate changes and stratospheric ozone depletion affect human health in various ways.Current mainstream epidemiologic research methods do not appear well adapted to analyze these health impacts, which involve complex systems influenced by human interventions or simpler processes that will take place in the future.This paper discusses a different paradigm for studying the health impacts of global environmental changes and focuses on the development of integrated ecoepidemiologic models using three examples-the effect of climate change on vector-borne diseases, the effect of climate change on thermal-related mortality, and the effects of increasing ultraviolet levels because of ozone depletion on the rates of skin cancer.-
RELATION OF FEEDS AND DIET TO THE VITAMIN CONTENT OF MILK
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A microprocessor computer program. An aid to the International System of Units
Authors: S. Ramanathan
Journal: JAMA (1980)

The transition from the scientific system of measurements used in the United States to the Système International creates difficulties for Americans who consult European or Canadian journals. Similar difficulties occur when they want to publish abroad. We have developed a program for the portable microcalculator, which may be coupled selectively to a recorder. Two types of programs are used on 7.5×1.5-cm electromagnetic cards. Program P<sub>1</sub>is used with the recorder and program P<sub>2</sub>with the calculator only. (<i>JAMA</i>244:165-166, 1980)
Copper Deficiency
Authors: Carmelo Gurnari, Heesun J. Rogers
Journal: New England Journal of Medicine (2021)

A 73-year-old woman was referred to the hematology clinic for evaluation of anemia. Bone marrow biopsy revealed trilineage hematopoietic maturation with severe dyserythropoiesis. Laboratory studies showed a low copper level, and the anemia resolved with copper supplementation.
Hypertensive Crisis
Authors: Edward D. Freis
Journal: JAMA (1969)

Hypertensive crisis is a medical emergency requiring early, expert, and intensive treatment. It is a life-threatening disorder characterized by acute or severe elevation of blood pressure and by clinical manifestations secondary to the hypertension and to associated arteriolar spasm or damage. The clinical manifestations may include encephalopathy, neuroretinitis, evidences of rapidly advancing renal impairment, and acute heart failure. A number of diseases can be associated with hypertensive crisis, the most common being the accelerated or malignant phase of essential hypertension. Renal diseases, such as acute and chronic glomerulonephritis, chronic pyelonephritis, collagen vascular disease, and renovascular hypertension also are frequent causes. Sudden elevations of blood pressure which may not be sustained but are severe enough to be lifethreatening can occur in patients with pheochromocytoma. In patients receiving treatment with monoamine oxidase inhibitors, a hypertensive crisis is precipitated by administration of sympathomimetic drugs, such as ephedrine or amphetamines, or by ingestion of
Standards and guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC). National Academy of Sciences - National Research Council
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Tolerogenic dendritic cells modulate pathogenic CD4+ T cells in an ex vivo co-culture system in a concanavalin A-mice model of type-I autoimmune hepatitis
Authors: Ranjana W. Minz, Prabhsimran Singh, Lekha Rani, Mohan Ramachandra Wani, Yashwant Kumar, Shashi Anand
Journal: Journal of Hepatology (2020)
Dr. A. B. Gunasekara
Authors: Hector Maclennan, D Anderson, Mr Ivar, Mcg Boden, Mr Wilkins, W Captain, H Boyd, T Antoine, H Edwards, A Liley, R Alder, D Barron, G Batchelor, A Bates, H Benny, R Blair, K Bland, M Bloom, Olga Bolitho, C Brown, F Bulwa, A Butcher
Journal: BMJ (1971)

More Cholera, Less Smallpox Last year 42,900 cases of cholera were re- ported from 40 countries to the World Health Organization, with 6,800 deaths.Many more certainly went unreported apart from in- apparent infections, which are usually more numerous in an outbreak than frank cases.This was the worst year since the El Tor outbreak began in 1961, and the most dangerous feature of it was the infection of Africa by the disease.In contrast the 30,000 cases of smallpox reported last year to the W.H.O. were a record low total.A 70% decrease in the number of cases followed the introduction of a world-wide eradication campaign by the W. H.O. in 1967.
Estimation of Safe Doses: Critical Review of the Hockey Stick Regression Method
Authors: Takemi Yanagimoto, Eiji Yamamoto
Journal: Environmental Health Perspectives (1979)

The hockey stick regression method is a convenient method to estimate safe doses, which is a kind of regression method using segmented lines. The method seems intuitively to be useful, but needs the assumption of the existence of the positive threshold value. The validity of the assumption is considered to be difficult to be shown. The alternative methods which are not based on the assumption, are given under suitable dose-response curves by introducing a risk level. Here the method using the probit model is compared with the hockey stick regression method. Computational results suggest that the alternative method is preferable. Furthermore similar problems in the case that response is measured as a continuous value are also extended. Data exemplified are concerned with relations of SO2 to simple chronic bronchitis, relations of photochemical oxidants to eye discomfort and residual antibiotics in the lever of the chicks. These data was analyzed by the original authors under the assumption of the existence of the positive threshold values.
The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers
Authors: M. Nemeth, L. Virag, O. Hala, A. Varro, G. Kovacs, D. Thormahlen, J. G. Papp
Journal: Cardiovascular Research (1996)

The cellular electrophysiological effects of 1 μM tedisamil (KC 8857) were studied in human atrial and ventricular fibers. Conventional microelectrode technique was applied to record the transmembrane action potentials at stimulation frequency of 100 per min and 37 °C. Tedisamil lengthened action potential duration (APD) more in atrial than in ventricular muscle fibers; prolongation of APD90 was 28.9 ± 3.3% (n = 6; p < 0.05) for atrial and 13.3 ± 5.2% (n = 6; P < 0.05) for ventricular tissue. The maximal rate of depolarization was depressed slightly, but significantly by 1 μM tedisamil only in ventricular fibers (12.9 ± 6.5%, n = 6, P < 0.05). From these cellular electrophysiological data it is concluded that the bradycardic/antiischemic agent tedisamil possesses marked Class III properties not only in cardiac tissues of experimental animals but also those of man.
Nephrology
Authors: Glenn M. Chertow
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Factors associated with NAFLD and advanced liver fibrosis and accuracy of liver biopsy in patients with diabetes mellitus type 2: a cross sectional study
Authors: Ivana Mikolasevic, Viktor Domislovic, Željko Krznarić, Nadija Skenderević, Božena Delija, Mia Klapan, Toni Jurić, Anđela Lukić, Petra Dinjar Kujundžić, Ana Ostojic, Petra Puž, Tajana Filipec Kanizaj
Journal: Journal of Hepatology (2020)
Abstract 20155: 15-year Outcomes and Predictors of Success for Percutaneous Mitral Commissurotomy for Rheumatic Mitral Stenosis
Authors: AlFazir Omar, Amin Ariff, Robaayah Zambahari, Rosli Mohd Ali
Journal: Circulation (2014)

Background: Rheumatic heart disease remains the most common acquired heart disease in children, especially in developing countries. This study aims to investigate the predictors of immediate procedural success and the immediate and long-term outcomes in patients undergoing percutaneous mitral commissurotomy (PTMC). Methods: A total of 1552 patients with rheumatic mitral stenosis and underwent PTMC from 1989 to 2012 were identified. We divided the group according to Wilkins score as low risk (≤5), intermediate risk (6-8) and high-risk (≥9). Procedural success was defined as mitral valve area greater than 1.0cm2 with a mean gradient of less than 10mmHg. Results: The median age was 36 years old [IQR 28-45]. The majority of patients was female (78.5%) and did not have any other valve involvements (85.0%). Most of cases were elective (99.5%) although 103 patients were pregnant (6.6%) during PTMC. The mitral valve area increased from 0.8cm2 [IQR 0.7-1.0] pre-procedure to 1.5cm2 [IQR 1.3-1.7] post-procedure, with a reduction in the mean pressure gradient of 15mmHg [IQR 12-20] to 4mmhg [IQR 2-6] post-procedure (all p&lt; 0.05). Using logistic regression analysis, no difference was seen in immediate procedural success between increasing age, previous PTMC, emergency cases, New York Heart Association status, balloon size or increasing risk groups (all p&gt;0.05). During the 15-year follow-up, the majority of patients were still alive. Conclusions: PTMC appears to be safe and effective in our population, irrespective of older age, higher NYHA class, higher Wilkins score and previous PTMC with good immediate and long-term outcomes.
Familial lupus erythematosus
Authors: D. Brustein
Journal: JAMA (1977)

The child of a woman with discoid lupus erythematosus (DLE) had lesions of DLE develop at the age of 2 months. The original lesions persisted and new lesions continued to develop to date; the child is now 28 montns old. In a second child, now 11 months old, a probable lupus erythematosus rash developed at 1 week of age. (<i>JAMA</i>238:2294-2296, 1977)